![[Key Takeaways from CDDF Live Webinar – “Compassionate Use and EAP for Cancer Drugs – From Fragmentation to a Common Framework in Europe under the New Legislation” (26 October 2026)]](https://cddf.org/wp-content/uploads/2026/10/CDDF-2026-Oct-Webinar-Compassionate-Use-Key-Takeaways-1-1080x675.jpg)
Multi-stakeholder Interview: Get an Inside Look at the CDDF Workshop on HTA in Cancer Drug Development
We are excited to share interview clips featuring a diverse group of stakeholders at CDDF & EORTC Joint Workshop on HTA in Cancer Drug Development. Held in Brussels on 5-6 October 2026, the meeting highlighted multi-stakeholder collaboration as the cornerstone of...![🔔 [Executive Summary Published: CDDF & EORTC Joint Workshop on HTA in Cancer Drug Development]](https://cddf.org/wp-content/uploads/2026/10/Thumbnail-image-1080x675.jpg)
🔔 [Executive Summary Published: CDDF & EORTC Joint Workshop on HTA in Cancer Drug Development]
We are delighted to announce that the executive summary of the CDDF & EORTC joint workshop on “Health Technology Assessment in Cancer Drug Development” has been published today. This multi-stakeholder workshop was held on 5-6 October 2026 in Brussels...
CDDF NEW WHITEPAPER: Improving Patient Access to New Treatment Modalities in European Cancer Care
We are delighted to announce that CDDF’s new whitepaper, Improving Patient Access to New Treatment Modalities in European Cancer Care, has been published in the Journal of Market Access & Health Policy this month. This paper highlights practical challenges and...